menu
    • menu

    Company profile for Context Therapeutics

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor (Onapristone XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) metastatic breast and ovarian cancers. In addition, Context is advancing CTX-030916, a potential best-in-class oral antiprogestin for the ...
    Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating new medicines to treat hormone-responsive cancers. Context’s lead program is Apristor (Onapristone XR), an investigational Phase 2 drug that is being developed for progesterone receptor positive (PR+) metastatic breast and ovarian cancers. In addition, Context is advancing CTX-030916, a potential best-in-class oral antiprogestin for the treatment of uterine fibroids and endometriosis, and a discovery-stage program targeting Sigma1

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Context TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3675 Market Street, Suite 200 Philadelphia, PA 19104
    Telephone
    Telephone
    267.225.7416
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.contexttherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/context-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Context_Tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Context Reports First Quarter 2026 Operating & Financial Results
    Context Reports First Quarter 2026 Operating & Financial Results

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289410/0/en/context-therapeutics-reports-first-quarter-2026-operating-and-financial-results.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Context' CTIM-76 Gets FDA Fast Track for Ovarian Cancer
    Context' CTIM-76 Gets FDA Fast Track for Ovarian Cancer

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267244/0/en/Context-Therapeutics-Announces-CTIM-76-Receives-FDA-Fast-Track-Designation-for-the-Treatment-of-Platinum-Resistant-Ovarian-Cancer.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Context Therapeutics Reports 2025 Financial Results
    Context Therapeutics Reports 2025 Financial Results

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260846/0/en/Context-Therapeutics-Reports-Full-Year-2025-Operating-and-Financial-Results.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Context Therapeutics Presents Poster At AACR Annual Meeting 2026
    Context Therapeutics Presents Poster At AACR Annual Meeting 2026

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258889/0/en/Context-Therapeutics-Announces-Poster-Presentation-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Context Therapeutics Joins Investor Conferences
    Context Therapeutics Joins Investor Conferences

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234427/0/en/Context-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Context Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
    Context Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220552/0/en/Context-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search